Page last updated: 2024-10-16

carnitine and Hyperchylomicronemia Late Onset

carnitine has been researched along with Hyperchylomicronemia Late Onset in 1 studies

Research Excerpts

ExcerptRelevanceReference
"L-Carnitine has been reported to reduce Lp(a) levels."2.84L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study. ( Bilianou, E; Elisaf, MS; Florentin, M; Liberopoulos, EN; Nikolaou, V; Pitsavos, C; Rizos, CV, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Florentin, M1
Elisaf, MS1
Rizos, CV1
Nikolaou, V1
Bilianou, E1
Pitsavos, C1
Liberopoulos, EN1

Trials

1 trial available for carnitine and Hyperchylomicronemia Late Onset

ArticleYear
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
    Lipids, 2017, Volume: 52, Issue:1

    Topics: Adult; Apolipoprotein B-100; Cardiovascular Diseases; Carnitine; Cholesterol; Double-Blind Method; D

2017